1. Pharmacovigilance: methods, recent developments and future perspectives

   • L. Härmark
   • A. C. van Grootheest

   Review Article 04 June 2008 Pages: 743 - 752

2. Clinical pharmacology and pharmacogenetics of thiopurines

   • Srikumar Sahasranaman
   • Danny Howard
   • Sandip Roy

   Review Article 28 May 2008 Pages: 753 - 767

   

3. Medication errors made by health care professionals. Analysis of the Finnish Poison Information Centre data between 2000 and 2007

   • Tapio Kuitunen
   • Pia Kuisma
   • Kalle Hoppu

   Clinical Trial 30 May 2008 Pages: 769 - 774

   

4. CYP3A induction and inhibition by different antiretroviral regimens reflected by changes in plasma 4β-hydroxycholesterol levels

   • F. Josephson
   • L. Bertilsson
   • U. Diczfalusy

   Pharmacodynamics 06 May 2008 Pages: 775 - 781

   

5. The importance of sample size, log-mean ratios, and intrasubject variability in the acceptance criteria of 108 bioequivalence studies

   • E. Ramirez
   • P. Guerra
   • J. Frias

   Pharmacokinetics and Disposition 21 May 2008 Pages: 783 - 793

   

6. Pharmacokinetic–pharmacodynamic modeling of the influence of chronic phenytoin therapy on the rocuronium bromide response in patients undergoing brain surgery

   • Juan Fernández-Candil
   • Pedro L. Gambús
   • Neus Fábregas

   Pharmacokinetics and Disposition 03 June 2008 Pages: 795 - 806

   

7. Prediction of cyclosporine A blood levels: an application of the adaptive-network-based fuzzy inference system (ANFIS) in assisting drug therapy

   • Sezer Gören
   • Adem Karahoca
   • M. Zafer Gören

   Pharmacokinetics and Disposition 06 May 2008 Pages: 807 - 814

   

8. Cholesterol in women at high cardiovascular risk is less successfully treated than in corresponding men

   • Anita Mehner
   • Ulf Lindblad
   • Kristina Bengtsson Boström

   Pharmacoepidemiology and Prescription 04 April 2008 Pages: 815 - 820

   

9. Outpatient antibiotic use and assessment of antibiotic guidelines in Chinese children’s hospitals

   • Wenshuang Zhang
   • Xuzhuang Shen
   • Yonghong Yang

   Pharmacoepidemiology and Prescription 06 May 2008 Pages: 821 - 828

   

10. Was the thrombotic risk of rofecoxib predictible from the French Pharmacovigilance Database before 30 September 2004?

    • A. Sommet
    • S. Grolleau
    • French Network of Regional Pharmacovigilance Centres

    Pharmacoepidemiology and Prescription 29 May 2008 Pages: 829 - 834